Search results for: 'Advances in Microbots'

17 Aug 2022  |  Global  |  Technology Research

Therapeutic Advances in Amyloidosis

Research Efforts and Technology Developments through Partnerships and Collaborations will Push New Therapeutic Modalities into Treatment Regimens.

Infographics

×

Amyloidosis is a rare disease caused by the accumulation and the deposition of proteins such as immunoglobulin light-chain protein in AL amyloidosis and misfolded transthyretin (TTR) protein in ATTR amyloidosis. There are a few other types of amyloidosis as well, which are either a result of a preexisting condition or are not highly prevalent. Vari...

This Technical Insights Research Service (RS) highlights technological advances that are enabling rehabilitation devices. Innovations in core technologies, incremental product enhancements, and convergence of different technologies are assessed. This global industry study, analyzes the market accelerators and challenges, recent IP activity in this ...

Since the advent of stem cells reprogramming after the discovery of the differentiation factors that allow the creation of human induced pluripotent stem cells, researchers all around the world are strongly committed to develop novel methods to design and build human stem cells. Indeed, there is an increasing demand for the more efficient product...

Monoclonal antibody therapeutics are being used for treatment of a wide array of diseases, specially in therapeutic areas such as oncology, immunology (including autoimmune and inflammatory diseases, as well as, transplant rejection) and neuroscience. The development of these new molecular agents, successfully directed to specific cellular targets,...

RNA therapeutics is a rapidly expanding field of next-generation medicine. RNA therapy typically comprises 4 different classes of molecules: non-codingRNA (ncRNA), antisense oligonucleotide (ASO), messengerRNA (mRNA), and RNA aptamer. Small ncRNAs are like a double-edged sword; they can either up- or down-regulate specific genes. Contrarily, long...

20 Dec 2022  |  Global  |  Technology Research

Advances and Growth Opportunities in RNA Vaccines

Technology Innovations and Investments Bolster Next-generation Prophylactic and Therapeutic RNA Vaccines

Infographics

×

RNA therapeutics and vaccines have been around for a long time, but the COVID-19 pandemic enabled their mass-market commercialization. Industry players saw mRNA vaccines developed for COVID-19 as effective for reducing the impact of the SARS-CoV-2 virus in populations. Moderna emerged as the first player to develop and commercialize an mRNA vaccine...

Therapeutically more effective drugs for the treatment of chronic diseases represents a crucial need. Biosimilars and biobetters offer the possibility to lower the cost of treating a variety of chronic diseases. In particular, biosimilars are the less expensive option; however, biobetters have demonstrated to be more effective, even over longer per...

29 Aug 2022  |  Global  |  Technology Research

Advancements in miRNA: Technology Assessment

Developments in miRNA sequencing and analysis are driving future growth potential in therapeutics and diagnostics

Infographics

×

Accelerated research around RNA-based therapeutics and diagnostics, accompanied by technology advancements in sequencing the human genome, has resulted in a better understanding of the role of miRNA in biological pathways, enhancing its potential in both therapeutics and diagnostics. The successful clinical validation of miRNA diagnostic tests has ...

Pharmacovigilance activities revolve around ensuring drug safety and preventing adverse drug reactions. While post marketing studies form the core of pharmacovigilance, inclusion of safety measures during clinical development and carrying out additional post marketing active surveillance is being utilized by a number of pharma companies.  Risks due...